Downstream process development considerations to address polysorbate degradation in drug substance formulation

被引：0
|
作者：
Yigzaw, Yinges [1 ]
Morris, Alex [1 ]
Sawant, Manali [1 ]
Gu, Jie [1 ]
机构：
[1] Genentech Inc, Purificat, San Francisco, CA 94080 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2017年 / 253卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
163-BIOT
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Development of BAF312 drug substance manufacturing process and analytical control strategy
    Koecher, Christian
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [22] Opportunities for Machine Learning and Artificial Intelligence to Advance Synthetic Drug Substance Process Development
    Griffin, Daniel J.
    Coley, Connor W.
    Frank, Scott A.
    Hawkins, Joel M.
    Jensen, Klavs F.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2023, 27 (11) : 1868 - 1879
  • [23] Assessing and mitigating pH-mediated DDI risks in drug development - formulation approaches and clinical considerations
    Wu, Di
    Liu, Jiaying
    Paragas, Erickson M.
    Yadav, Jaydeep
    Aliwarga, Theresa
    Heimbach, Tycho
    Escotet-Espinoza, M. Sebastian
    DRUG METABOLISM REVIEWS, 2024,
  • [24] The Degradation Map Process - A Tool for Obtaining a Lean Stability Strategy in Drug Development
    Traff, Annika M.
    Ottosson, Jenny
    Andersson, Thomas
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 111 (07) : 1918 - 1925
  • [25] Neurofunctional test batteries in safety pharmacology - Current and emerging considerations for the drug development process
    Jackson, Samuel J.
    Authier, Simon
    Brohmann, Henning
    Goody, Susan M. G.
    Jones, David
    Prior, Helen
    Rosch, Anke
    Traebert, Martin
    Tse, Karen
    Valentin, Jean Pierre
    Milne, Aileen
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2019, 100
  • [26] Development and validation of a capillary electrophoretic method for the determination of degradation product in naphazoline HCl bulk drug substance
    Yesilada, A
    Tozkoparan, B
    Gokhan, N
    Oner, L
    Ertan, M
    JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 1998, 21 (17) : 2575 - 2588
  • [27] Food and Drug Administration Public Workshop Summary-Development Considerations of Antifungal Drugs to Address Unmet Medical Need
    Yasinskaya, Yuliya
    Bala, Shukal
    Waack, Ursula
    Dixon, Cheryl
    Higgins, Karen
    Moore, Jason N.
    Jjingo, Caroline J.
    O'Shaughnessy, Elizabeth
    Colangelo, Philip
    Botgros, Radu
    Nambiar, Sumathi
    Angulo, David
    Dane, Aaron
    Chiller, Tom
    Hodges, Michael R.
    Sandison, Taylor
    Hope, William
    Walsh, Thomas J.
    Pappas, Peter
    Katragkou, Aspasia
    Kovanda, Laura
    Rex, John H.
    Marr, Kieren A.
    Ostrosky-Zeichner, Luis
    Sekine, Shohko
    Deshpande, Monika
    Shukla, Sunita J.
    Farley, John
    CLINICAL INFECTIOUS DISEASES, 2023, 77 (03) : 380 - 387
  • [28] Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: Formulation development, stability issues, basic considerations and applications
    Rai, Vineet Kumar
    Mishra, Nidhi
    Yadav, Kuldeep Singh
    Yadav, Narayan Prasad
    JOURNAL OF CONTROLLED RELEASE, 2018, 270 : 203 - 225
  • [29] Recent Progression in Nanocarrier based Techniques to Address Fungal Infections and Patent Status in Drug Development Process
    Singh, Ravi Pratap
    Narang, Raj Kumar
    Singh, Amrinder
    RECENT PATENTS ON NANOTECHNOLOGY, 2025, 19 (02) : 183 - 204
  • [30] ROUTE SCOUTING, PROCESS OPTIMIZATION, AND SCALE-UP CONSIDERATIONS: DRUG DEVELOPMENT FIRMS AND CROs
    Kulp, Christopher
    CHIMICA OGGI-CHEMISTRY TODAY, 2018, 36 (04) : 33 - 34
12345